Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French pharmaceutical group specialized in the field of nuclear medicine. The Swiss pharmaceutical company will buy Advanced Accelator Applications in a deal valued at $3.9 billion and in efforts to strengthen its oncology business. The company has entered into a memorandum … Continue reading “Novartis to Buy This Big French Drug Maker for $3.9 Billion”
